Crescendo Biologics was able to gather £17.5 million or $28 million from lead investor Imperial Innovations for its Series A round. Astellas Venture Management and Sofinnova Partners also participated in the financing.
Sofinnova Partners
Breaking News
The following bids, mergers, acquisitions and disposals were reported on Monday including Forbes, Axel Springer, MidCap Financial LLC, Goldman Sachs and others.
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- Brazilian Woman Wheels Her Dead Uncle Into the Bank to Withdraw Loan in His Name
- Australian Farmer Prepares Grave of 3,000 Sheep After Failing to Find Buyer
- Tech Giants Gear Up for Earnings Showdown; Investors Await if AI Strategies Turned Into Profits
- Netflix Exceeds Projections with 9.33 Million New Subscribers in Q1, Hitting Nearly 270 Million Total
- Stability AI Cuts 10% of Its Workforce Following the Controversial Exit of Its CEO
- Trump Media Investors Finally See Uptick in Their Shares for 2 Straight Days
